These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12781796)

  • 1. [Prevent and cure insulin-dependent diabetes].
    Bach JF
    Pathol Biol (Paris); 2003 Apr; 51(3):151-5. PubMed ID: 12781796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of insulin-dependent diabetes mellitus.
    Masteller EL; Bluestone JA
    Curr Opin Immunol; 2002 Oct; 14(5):652-9. PubMed ID: 12183168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
    Chatenoud L; Thervet E; Primo J; Bach JF
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):123-7. PubMed ID: 8278351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinic.
    Chatenoud L; Waldmann H
    Rev Diabet Stud; 2012; 9(4):372-81. PubMed ID: 23804274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to islet autoantigens in type 1 diabetes.
    Bach JF; Chatenoud L
    Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?
    Chatenoud L
    Nat Rev Endocrinol; 2010 Mar; 6(3):149-57. PubMed ID: 20173776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [One step towards restoration of self-tolerance in human autoimmune diseases].
    Chatenoud L
    Med Sci (Paris); 2007 Feb; 23(2):167-71. PubMed ID: 17291426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypically distinct anti-insulin B cells repopulate pancreatic islets after anti-CD20 treatment in NOD mice.
    Boldison J; Da Rosa LC; Buckingham L; Davies J; Wen L; Wong FS
    Diabetologia; 2019 Nov; 62(11):2052-2065. PubMed ID: 31444529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does autoantigen administration inhibit recurrence of type 1 diabetes in transplanted islets?
    Mojtahedi Z; Farjadian S; Ghaderi A
    Med Hypotheses; 2005; 64(5):986-8. PubMed ID: 15780496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-specific tolerance in diabetes.
    Gottlieb PA; Eisenbarth GS
    Clin Immunol; 2002 Jan; 102(1):2-11. PubMed ID: 11781061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administering glutamic acid decarboxylase to NOD mice prevents diabetes.
    Tisch R; Yang XD; Liblau RS; McDevitt HO
    J Autoimmun; 1994 Dec; 7(6):845-50. PubMed ID: 7888040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
    Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
    J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
    Dotta F; Eisenbarth GS
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of type 1 diabetes after anti-CD3 antibody treatment and transplantation of embryonic pancreatic precursors.
    Begum S; Chen W; Herold KC; Papaioannou VE
    Endocrinology; 2009 Oct; 150(10):4512-20. PubMed ID: 19589867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term administration of anti-L3T4 MoAb prevents diabetes in NOD mice.
    Kurasawa K; Sakamoto A; Maeda T; Sumida T; Ito I; Tomioka H; Yoshida S; Koike T
    Clin Exp Immunol; 1993 Mar; 91(3):376-80. PubMed ID: 8095192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice.
    Charlton B; Taylor-Edwards C; Tisch R; Fathman CG
    J Autoimmun; 1994 Oct; 7(5):549-60. PubMed ID: 7840850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of type 1 diabetes with anti-CD3 monoclonal antibody.
    Glandt M; Hagopian W; Herold KC
    Rev Endocr Metab Disord; 2003 Dec; 4(4):361-8. PubMed ID: 14618021
    [No Abstract]   [Full Text] [Related]  

  • 20. Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley AN
    Transpl Immunol; 2002 Jun; 10(1):63-72. PubMed ID: 12182467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.